Scavenging Reactive Lipids to Prevent Oxidative Injury

Abstract

Oxidative injury due to elevated levels of reactive oxygen species is implicated in cardiovascular diseases, Alzheimer's disease, lung and liver diseases, and many cancers. Antioxidant therapies have generally been ineffective at treating these diseases, potentially due to ineffective doses but also due to interference with critical host defense and signaling processes. Therefore, alternative strategies to prevent oxidative injury are needed. Elevated levels of reactive oxygen species induce lipid peroxidation, generating reactive lipid dicarbonyls. These lipid oxidation products may be the most salient mediators of oxidative injury, as they cause cellular and organ dysfunction by adducting to proteins, lipids, and DNA. Small-molecule compounds have been developed in the past decade to selectively and effectively scavenge these reactive lipid dicarbonyls. This review outlines evidence supporting the role of lipid dicarbonyls in disease pathogenesis, as well as preclinical data supporting the efficacy of novel dicarbonyl scavengers in treating or preventing disease. Expected final online publication date for the Annual Review of Pharmacology and Toxicology, Volume 61 is January 7, 2021. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.

Exosomal delivery of therapeutic modulators through the blood–brain barrier; promise and pitfalls

“…By using precise molecular mechanisms, these barriers maintain the rigorously regulated microenvironment by pushing strict control on passages of various ions and influx of biomolecules to the brain [ 11 , 12 ]. At the same time, they can simultaneously clear and scavenge the toxins and byproducts away from the brain to the systemic circulation via specialized structures like P-glycoproteins [ 13 , 14 ].…”

CART mitigates oxidative stress and DNA damage in memory deficits of APP/PS1 mice via upregulating β‑amyloid metabolism‑associated enzymes

“…Moreover, it has been reported that oxidative stress serves a vital role in the pathological processes of AD, causing damage to the body when the generation of oxygen free radicals exceeds the limits of the antioxidant system in the pathological environment (9). The available treatment strategies for AD function via suppressing the formation of Aβ, preventing the accumulation of Aβ to form SPs, reducing the amount of lysis in the brain and depolymerizing SPs (10)(11)(12). Transcription factor EB, which regulates C99 accumulation in AD cellular models, serves as a potential strategy to prevent the accumulation of this early neurotoxic catabolite (7).…”

Direct Detection of Isolevuglandins in Tissues using a D11 scFv-Alkaline Phosphatase Fusion Protein and Immunofluorescence

“…Isolevuglandins (IsoLGs), also known as isoketals, are isomers of the 4-ketoaldehyde family, which are products of lipid peroxidation, and react with and adduct to primary amines on proteins 1 , 2 . IsoLGs have been implicated in several diseases, including cardiovascular, Alzheimer's, lung and liver diseases, and many types of cancer 3 . IsoLGs have been most extensively studied in their contribution to cardiovascular disease (CVD), which is a significant health and economic burden globally, including the United States.…”